Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Organisation › Details

Pharvaris B.V.

Pharvaris (Nasdaq: PHVS) is a clinical-stage biopharmaceutical company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. Pharvaris brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. *

 

Period Start 2016-04-07 existent
Period End 2021-02-04 reorganised
  Today Pharvaris N.V. (Nasdaq: PHVS)
  Successor Pharvaris N.V. (Nasdaq: PHVS)
Products Industry pharmaceutical
  Industry 2 PHA121 (incl in soft capsules as PHVS416) (Pharvaris)
Person Person Modig, Berndt (Pharvaris CEO before Prosensa 201003 CFO before Jerini 200310– CFO before Surplex AG)
     
Region Region Netherlands_oo
  Country Netherlands
  Street 21 J.H. Oortweg
  City 2333 CH Leiden
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Pharvaris N.V.. (2/4/21). "Press Release: Pharvaris Announces Pricing of Upsized Initial Public Offering". Zug.
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Pharvaris B.V.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top